We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Pivotal European Study Results Show Innovative Cancer Diagnostic Technology

By MedImaging International staff writers
Posted on 27 Dec 2016
Image: The diagram describes the principle of the photoacoustic effect and imaging used in the SENO Medical Imagio modality (Photo courtesy of Ultrasonography).
Image: The diagram describes the principle of the photoacoustic effect and imaging used in the SENO Medical Imagio modality (Photo courtesy of Ultrasonography).
A medical imaging company that pioneered a novel opto-acoustic breast-imaging technology has released new down-classification and up-classification data from a European post-market surveillance and clinical follow-up study called MAESTRO.

The final results of the MAESTRO study are expected to be released in early 2017, while the results from another large-scale trial of the technology in the US called PIONEER that includes more than 2,000 patients are planned to be released in the second half of 2017.

Seno Medical Instruments (San Antonia, TX, USA) is developing and commercializing the Imagio opto-acoustic breast-cancer diagnostics imaging modality. The solution combines results from the Imagio system with ultrasound scans to produce functional and anatomical images of the breast, including a color map for suspicious breast masses, with standard anatomic ultrasound images. The new modality could help radiologists confirm or rule out malignancy in breast tumors without the use of ionizing radiation or contrast agents.

Medical Director of SENO Medical, Thomas Stavros, MD, said, "The Imagio breast imaging system represents a significant advance to improve the diagnoses of breast cancer by helping to determine the appropriate classification of breast masses. The presentation of the histological data will be of particular interest to the oncology community as it will identify a correlation between the opto-acoustic imaging findings and histologic grade of the breast masses."

Related Links:
Seno Medical Instruments

New
High-Precision QA Tool
DEXA Phantom
X-ray Diagnostic System
FDX Visionary-A
New
Diagnostic Ultrasound System
DC-80A
New
Post-Processing Imaging System
DynaCAD Prostate

Channels

Ultrasound

view channel
Image: The new implantable device for chronic pain management is small and flexible (Photo courtesy of The Zhou Lab at USC)

Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery

Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.